tiprankstipranks
Mirum Pharmaceuticals Inc (MIRM)
NASDAQ:MIRM
Holding MIRM?
Track your performance easily

Mirum Pharmaceuticals (MIRM) Financial Statements

648 Followers

Mirum Pharmaceuticals Financial Overview

Mirum Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-2.067; its P/E ratio is -21.03; Mirum Pharmaceuticals is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 90.38M$ 77.88M$ 69.22M$ 69.55M$ 47.73M
Gross Profit$ 90.38M$ 77.88M$ 69.22M$ 39.55M$ 37.50M
EBIT$ -13.89M$ -24.00M$ -3.25M$ -31.87M$ -19.77M
EBITDA$ -7.41M$ -17.74M$ 2.83M$ -26.38M$ -17.10M
Net Income Common Stockholders$ -14.23M$ -24.64M$ -25.28M$ -35.66M$ -23.59M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 284.44M$ 278.37M$ 302.84M$ 286.33M$ 306.03M
Total Assets$ 667.89M$ 660.75M$ 651.96M$ 646.62M$ 650.64M
Total Debt$ 317.65M$ 316.56M$ 307.52M$ 308.14M$ 307.97M
Net Debt$ 33.21M$ 38.19M$ 4.68M$ 21.82M$ 1.94M
Total Liabilities$ 435.87M$ 431.77M$ 417.36M$ 397.95M$ 381.56M
Stockholders Equity$ 232.02M$ 228.94M$ 234.60M$ 248.67M$ 269.08M
Cash Flow-
Free Cash Flow$ -6.20M$ -14.58M$ 15.20M$ -21.62M$ -18.22M
Operating Cash Flow$ 3.98M$ -3.80M$ 15.21M$ -16.62M$ -18.22M
Investing Cash Flow$ -18.04M$ -72.72M$ -13.00K$ -2.00M$ -182.76M
Financing Cash Flow$ 3.86M$ 7.29M$ 1.21M$ 1.78M$ 207.13M
Currency in USD

Mirum Pharmaceuticals Earnings and Revenue History

Mirum Pharmaceuticals Debt to Assets

Mirum Pharmaceuticals Cash Flow

Mirum Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis